#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vaginal cancer Systemic mastocytosis Chronic graft versus host disease in skin Frontotemporal dementia Ovarian cancer stage III Desmoplastic small round cell tumour Liver abscess Mastocytosis Microvillous inclusion disease Juvenile chronic myelomonocytic leukaemia Usher's syndrome Osteosarcoma recurrent Measles Neuroendocrine carcinoma Marginal zone lymphoma More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia – Diagnostics Tuberous sclerosis complex – Basic Information Glycogen storage disease type I – Basic Information Chordoma – Diagnostics Bronchiolitis obliterans syndrome – Trials in Disease Pleural mesothelioma malignant – Treatment Gaucher’s disease type III Synovial sarcoma – Life with Disease Alport’s syndrome – Basic Information Splenic marginal zone lymphoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Triheptanoin Azathioprine Gns561 Desflurane JX10 Berotralstat Sultiame Nido-361 Olopatadine Prednisolone Sodium Succinate ABIRATERONE DECANOATE Mirtazapine ADCE-D01 S227928 Isoprenaline Hydrochloride PF-07868489 Azd8421 Mps-112 Chlorhexidine Gluconate Mecillinam More therapies…

    Learn about Your Condition

    Retroperitoneal cancer Colorectal adenocarcinoma Prostate cancer recurrent Hand fracture Muscular dystrophy Ovarian cancer recurrent Ulcerative keratitis Pituitary tumour benign Anal squamous cell carcinoma Agitation Neck pain Pancreatitis chronic Inborn error of metabolism Penile cancer Langerhans cell sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Attention deficit hyperactivity disorder

  • Study on the Effects of Methylphenidate on Brain Function in Adults with ADHD, with or without Mood Disorders, Compared to Placebo

    Recruiting

    4 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    France

  • Study on How Methylphenidate Works in Adults with ADHD, Comparing Those with and Without Obesity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    France

  • Study on Melatonin and Quetiapine for Treating Insomnia in Adolescents with Psychiatric Disorders

    Recruiting

    4 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    • Schizoaffective disorder
    • Insomnia
    Investigated Drugs:
    • Melatonin
    • Quetiapine
    Denmark

  • Study on the Safety and Effectiveness of Dexamfetamine Sulfate for Adults with ADHD and Moderate to Severe Depression

    Recruiting

    2 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    • Major depression
    Investigated Drugs:
    • Dexamfetamine Sulfate
    Germany

  • Study on Lisdexamfetamine and Methylphenidate for Children with ADHD and Type 1 Diabetes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Lisdexamfetamine Dimesylate
    • Methylphenidate Hydrochloride
    Poland

  • Microdosing lysergide (20 µg) to improve symptoms, emotion regulation and sleep in adults with ADHD

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    Investigated Drugs:
    • LYSERGIDE
    The Netherlands
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!